Pharmacologic Management of Type 2 Diabetes

被引：99

作者：

Harper, William ^{[1
,2
]}

Clement, Maureen ^{[3
]}

Goldenberg, Ronald ^{[4
,5
]}

Hanna, Amir ^{[6
]}

Main, Andrea ^{[7
]}

Retnakaran, Ravi ^{[8
]}

Sherifali, Diana

Woo, Vincent ^{[9
]}

Yale, Jean-Francois ^{[10
]}

机构：

[1] McMaster Univ, Div Endocrinol, Hamilton, ON, Canada

[2] McMaster Univ, Div Internal Med, Hamilton, ON, Canada

[3] Univ British Columbia, Ctr Diabet, Vernon, BC, Canada

[4] North York Gen Hosp, Thronhill, ON, Canada

[5] LMC Endocrinol & Diabet, Thronhill, ON, Canada

[6] Univ Toronto, Dept Med, Toronto, ON, Canada

[7] Univ Waterloo, Sch Pharm, Grandview Med Ctr Family Hlth Team, Waterloo, ON N2L 3G1, Canada

[8] Univ Toronto, Dept Med, Div Endocrinol & Metab, Toronto, ON, Canada

[9] Univ Manitoba, John Buhler Res Ctr, Sect Endocrinol & Metab, Winnipeg, MB, Canada

[10] McGill Univ, McGill Nutr & Food Sci Ctr, Montreal, PQ, Canada

来源：

CANADIAN JOURNAL OF DIABETES | 2013年 / 37卷

关键词：

INTENSIVE INSULIN THERAPY; IMPROVES GLYCEMIC CONTROL; PEPTIDASE-4 INHIBITOR SITAGLIPTIN; DOSE COMBINATION THERAPY; DOUBLE-BLIND; BASAL INSULIN; CARDIOVASCULAR OUTCOMES; GLUCOSE CONTROL; PIOGLITAZONE HYDROCHLORIDE; OBESE-PATIENTS;

D O I：

10.1016/j.jcjd.2013.01.021

中图分类号：

R5 [内科学];

学科分类号：

100201 [内科学];

摘要：

[No abstract available]

引用

页码：S61 / S68

页数：8

共 111 条

[1]

VETERANS AFFAIRS COOPERATIVE STUDY ON GLYCEMIC CONTROL AND COMPLICATIONS IN TYPE-II DIABETES (VA CSDM) - RESULTS OF THE FEASIBILITY TRIAL [J].

ABRAIRA, C ;

COLWELL, JA ;

NUTTALL, FQ ;

SAWIN, CT ;

NAGEL, NJ ;

COMSTOCK, JP ;

EMANUELE, NV ;

LEVIN, SR ;

HENDERSON, W ;

LEE, HS .

DIABETES CARE, 1995, 18 (08) :1113-1123

[2]

Twelve- and 52-week efficacy of the dipeptidyl peptidase IV inhibitor LAF237 in metformin-treated patients with type 2 diabetes [J].

Ahrén, B ;

Gomis, R ;

Standl, E ;

Mills, D ;

Schweizer, A .

DIABETES CARE, 2004, 27 (12) :2874-2880

[3]

Amer Diabet Assoc, 1998, DIABETES CARE, V21, P2180

[4]

Efficacy and safety of incretin therapy in type 2 diabetes - Systematic review and meta-analysis [J].

Amori, Renee E. ;

Lau, Joseph ;

Pittas, Anastassios G. .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2007, 298 (02) :194-206

[5]

Mealtime treatment with insulin analog improves postprandial hyperglycemia and hypoglycemia in patients with non-insulin-dependent diabetes mellitus [J].

Anderson, JH ;

Brunelle, RL ;

Keohane, P ;

Koivisto, VA ;

Trautmann, ME ;

Vignati, L ;

DiMarchi, R .

ARCHIVES OF INTERNAL MEDICINE, 1997, 157 (11) :1249-1255

[6]

Improved mealtime treatment of diabetes mellitus using an insulin analogue [J].

Anderson, JH ;

Brunelle, RL ;

Koivisto, VA ;

Trautmann, ME ;

Vignati, L ;

DiMarchi, R ;

Cameron, DP ;

Yeu, DK ;

Zimmet, P ;

Lauvaux, JP ;

VanGaal, LF ;

Chiasson, JL ;

Fettes, IM ;

Tan, MH ;

Toth, EL ;

Charbonnel, B ;

Selam, JL ;

Haslbeck, M ;

SchulzeSchleppinghoff, B ;

Karasik, A ;

Hazenberg, HJ ;

VanDoorn, LG ;

Bonnici, FB ;

Hough, S ;

Mollentze, WF ;

Moore, R ;

Omar, MA ;

Robertson, LI ;

VanRooyen, RJ ;

DeLeiva, A ;

Jara, A ;

Vazquez, JA ;

Arslanian, S ;

Bastyr, EJ ;

Bergenstal, RM ;

Blonde, L ;

Boyce, PA ;

Chase, HP ;

Clarke, DH ;

Davidson, J ;

Garber, A ;

Goldberg, RB ;

Guthrie, RA ;

Mayfield, RK ;

Mengel, MC ;

Prince, MJ ;

Reeves, ML ;

Rosenzweig, JL ;

Schade, DS ;

Soeldner, JS .

CLINICAL THERAPEUTICS, 1997, 19 (01) :62-72

[7]

[Anonymous], BMJ

[8]

Further Improvement in Postprandial Glucose Control With Addition of Exenatide or Sitagliptin to Combination Therapy With Insulin Glargine and Metformin A proof-of-concept study [J].

Arnolds, Sabine ;

Dellweg, Sibylle ;

Clair, Janina ;

Dain, Marie-Paule ;

Nauck, Michael A. ;

Rave, Klaus ;

Kapitza, Christoph .

DIABETES CARE, 2010, 33 (07) :1509-1515

[9]

Pioglitazone hydrochloride monotherapy improves glycemic control in the treatment of patients with type 2 diabetes - A 6-month randomized placebo-controlled dose-response study [J].

Aronoff, S ;

Rosenblatt, S ;

Braithwaite, S ;

Egan, JW ;

Mathisen, AL ;

Schneider, RL .

DIABETES CARE, 2000, 23 (11) :1605-1611

[10]

Effect of the dipeptidyl peptidase-4 inhibitor sitagliptin as monotherapy on glycemic control in patients with type 2 diabetes [J].

Aschner, Pablo ;

Kipnes, Mark S. ;

Lunceford, Jared K. ;

Sanchez, Matilde ;

Mickel, Carolyn ;

Williams-Herman, Debora E. .

DIABETES CARE, 2006, 29 (12) :2632-2637

← 1 2 3 4 5 6 7 8 9 10 →